Literature DB >> 7861186

The folate receptor in central nervous system malignancies of childhood.

S D Weitman1, K M Frazier, B A Kamen.   

Abstract

The folate receptor is a membrane linked glycoprotein that participates in the cellular accumulation of 5-methyltetrahydrofolic acid, methotrexate and 5,10-dideazatetrahydrofolic acid. Relative receptor overexpression has been observed in several malignant cell lines and tissues. In this study we determined receptor expression using western blot analysis in primary pediatric malignancies involving the central nervous system. This study suggests that ependymoma tumors have a high frequency of receptor expression which may reflect a specific cytogenetic abnormality or the cellular origin of these tumors. The potential role in developing selective chemotherapy mediated by the folate receptor is also discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7861186     DOI: 10.1007/bf01052894

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  26 in total

1.  Homologous membrane folate binding proteins in human placenta: cloning and sequence of a cDNA.

Authors:  M Ratnam; H Marquardt; J L Duhring; J H Freisheim
Journal:  Biochemistry       Date:  1989-10-03       Impact factor: 3.162

2.  Isolation and characterization of a folate receptor from human placenta.

Authors:  A C Antony; C Utley; K C Van Horne; J F Kolhouse
Journal:  J Biol Chem       Date:  1981-09-25       Impact factor: 5.157

3.  Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas.

Authors:  J R Berenson; J Yang; R A Mickel
Journal:  Oncogene       Date:  1989-09       Impact factor: 9.867

4.  Monoclonal antibody against ependymoma-derived cell line.

Authors:  Y Mihara; Y Matsukado; S Goto; Y Ushio; S Tokumitsu; K Takahashi
Journal:  J Neurooncol       Date:  1992-01       Impact factor: 4.130

5.  Characterization of two cDNAs encoding folate-binding proteins from L1210 murine leukemia cells. Increased expression associated with a genomic rearrangement.

Authors:  K E Brigle; E H Westin; M T Houghton; I D Goldman
Journal:  J Biol Chem       Date:  1991-09-15       Impact factor: 5.157

6.  Properties of a folate binding protein (FBP) isolated from porcine kidney.

Authors:  B A Kamen; J D Caston
Journal:  Biochem Pharmacol       Date:  1986-07-15       Impact factor: 5.858

7.  Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity.

Authors:  S Miotti; S Canevari; S Ménard; D Mezzanzanica; G Porro; S M Pupa; M Regazzoni; E Tagliabue; M I Colnaghi
Journal:  Int J Cancer       Date:  1987-03-15       Impact factor: 7.396

8.  Further observations on the folate-binding factor in some leukemic cells.

Authors:  S P Rothenberg; M DaCosta
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

9.  Characterization of a candidate bcl-1 gene.

Authors:  D A Withers; R C Harvey; J B Faust; O Melnyk; K Carey; T C Meeker
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

10.  Human T-lymphocytes targeted against an established human ovarian carcinoma with a bispecific F(ab')2 antibody prolong host survival in a murine xenograft model.

Authors:  D Mezzanzanica; M A Garrido; D S Neblock; P E Daddona; S M Andrew; V R Zurawski; D M Segal; J R Wunderlich
Journal:  Cancer Res       Date:  1991-10-15       Impact factor: 12.701

View more
  23 in total

1.  Synthesis of folate-functionalized RAFT polymers for targeted siRNA delivery.

Authors:  Danielle S W Benoit; Selvi Srinivasan; Andrew D Shubin; Patrick S Stayton
Journal:  Biomacromolecules       Date:  2011-06-10       Impact factor: 6.988

2.  Folate-immunoglobulin G as an anticancer therapeutic antibody.

Authors:  Hong Li; Yanhui Lu; Longzhu Piao; Jun Wu; Xiaojuan Yang; Sri Vidya Kondadasula; William E Carson; Robert J Lee
Journal:  Bioconjug Chem       Date:  2010-05-19       Impact factor: 4.774

3.  Quantification of endocytosis using a folate functionalized silica hollow nanoshell platform.

Authors:  Sergio Sandoval; Natalie Mendez; Jesus G Alfaro; Jian Yang; Sharraya Aschemeyer; Alex Liberman; William C Trogler; Andrew C Kummel
Journal:  J Biomed Opt       Date:  2015-08       Impact factor: 3.170

4.  Ligand-decorated click polypeptide derived nanoparticles for targeted drug delivery applications.

Authors:  Mohiuddin A Quadir; Stephen W Morton; Lawrence B Mensah; Kevin Shopsowitz; Jeroen Dobbelaar; Nicole Effenberger; Paula T Hammond
Journal:  Nanomedicine       Date:  2017-03-02       Impact factor: 5.307

5.  Blood-brain barrier transport of reduced folic acid.

Authors:  D Wu; W M Pardridge
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

6.  Targeting folate receptor β positive tumor-associated macrophages in lung cancer with a folate-modified liposomal complex.

Authors:  Yan Tie; Heng Zheng; Zhiyao He; Jingyun Yang; Bin Shao; Li Liu; Min Luo; Xia Yuan; Yu Liu; Xiangxian Zhang; Hongyi Li; Min Wu; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2020-01-22

7.  Case control study of periconceptional folic acid intake and nervous system tumors in children.

Authors:  Juan Antonio Ortega-García; Josep Ferrís-Tortajada; Luz Claudio; Offie Porat Soldin; Miguel Felipe Sanchez-Sauco; Jose Luís Fuster-Soler; Juan Francisco Martínez-Lage
Journal:  Childs Nerv Syst       Date:  2010-05-23       Impact factor: 1.475

Review 8.  Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues.

Authors:  Rongbao Zhao; Larry H Matherly; I David Goldman
Journal:  Expert Rev Mol Med       Date:  2009-01-28       Impact factor: 5.600

9.  Clinical pharmacokinetics and exposure-toxicity relationship of a folate-Vinca alkaloid conjugate EC145 in cancer patients.

Authors:  Jing Li; Edward A Sausville; Patrick J Klein; David Morgenstern; Christopher P Leamon; Richard A Messmann; Patricia LoRusso
Journal:  J Clin Pharmacol       Date:  2009-10-16       Impact factor: 3.126

10.  Post-Synthetic Modification Nanoscale Metal-Organic Frameworks for Targeted Drug Delivery in Cancer Cells.

Authors:  Baochun Yang; Mei Shen; Jianqiang Liu; Fei Ren
Journal:  Pharm Res       Date:  2017-09-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.